IMMUNITYBIO, INC. (IBRX)
ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting
ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting
NEUPATH HEALTH TO REPORT Q1 2026 RESULTS AND HOST INVESTOR WEBINAR
Telesat reports results for the quarter ended March 31, 2026
Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge
AGCO REPORTS FIRST-QUARTER RESULTS
Cummins Delivered Strong Operating Results and Returned $519 Million to Shareholders in the First Quarter of 2026; Raises Full-year Outlook
Fortive To Present at 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference
Kura Oncology to Report First Quarter 2026 Financial Results
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
VSE Corporation Completes Acquisition of Precision Aviation Group